Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

ALZHEIMER DISEASE

Neuropsychiatric symptoms in AD: the search for mechanisms

New work building on the results of genome-wide association studies in Alzheimer disease has identified molecular mechanisms that are shared with some psychiatric disorders. The study leveraged ‘omics data and has the realistic potential to elucidate unknown disease mechanisms; however, a lack of information about neuropsychiatric symptoms in the participants with Alzheimer disease limits the conclusions.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Steinberg, M. et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int. J. Geriatr. Psychiatry 23, 170–177 (2008).

    Article  Google Scholar 

  2. Maust, D. T. et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry 72, 438–445 (2015).

    Article  Google Scholar 

  3. Wingo, T. S. et al. Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat. Commun. 13, 4314 (2022).

    CAS  Article  Google Scholar 

  4. Ismail, Z. et al. Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities. Nat. Rev. Neurol. 18, 131–144 (2022).

    Article  Google Scholar 

  5. DeMichele-Sweet, M. A. A. et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol. Psychiatry 26, 5797–5811 (2021).

    CAS  Article  Google Scholar 

  6. Pishva, E. et al. Psychosis-associated DNA methylomic variation in Alzheimer’s disease cortex. Neurobiol. Aging 89, 83–88 (2020).

    CAS  Article  Google Scholar 

  7. Creese, B. et al. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease. Transl. Psychiatry 9, 273 (2019).

    Article  Google Scholar 

  8. Johar, I. et al. Genome-wide association of Alzheimer’s disease with dysphoria and evaluation of genetic overlap with major depressive disorder. Alzheimers Dement. 15, 621–622 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

B.C. and K.L. are supported by the National Institute On Aging of the National Institutes of Health under award number R01AG067015. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Byron Creese.

Ethics declarations

Competing interests

The authors report no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Creese, B., Lunnon, K. Neuropsychiatric symptoms in AD: the search for mechanisms. Nat Rev Neurol (2022). https://doi.org/10.1038/s41582-022-00721-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41582-022-00721-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing